[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3033576B1 - METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE - Google Patents

METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE Download PDF

Info

Publication number
FR3033576B1
FR3033576B1 FR1500500A FR1500500A FR3033576B1 FR 3033576 B1 FR3033576 B1 FR 3033576B1 FR 1500500 A FR1500500 A FR 1500500A FR 1500500 A FR1500500 A FR 1500500A FR 3033576 B1 FR3033576 B1 FR 3033576B1
Authority
FR
France
Prior art keywords
biological sample
inactivating
infectious agent
microorganism
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1500500A
Other languages
French (fr)
Other versions
FR3033576A1 (en
Inventor
Remi Charrel
Didier Raoult
Pierre Yves Levy
Bernard La Scola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pocrame
Aix Marseille Universite
Centre National de la Recherche Scientifique CNRS
Fondation Mediterranee Infection
Original Assignee
Pocrame
Aix Marseille Universite
Centre National de la Recherche Scientifique CNRS
Fondation Mediterranee Infection
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pocrame, Aix Marseille Universite, Centre National de la Recherche Scientifique CNRS, Fondation Mediterranee Infection filed Critical Pocrame
Priority to FR1500500A priority Critical patent/FR3033576B1/en
Publication of FR3033576A1 publication Critical patent/FR3033576A1/en
Application granted granted Critical
Publication of FR3033576B1 publication Critical patent/FR3033576B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/38—Diluting, dispersing or mixing samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une méthode de traitement d'un échantillon biologique de prélèvement clinique de patient humain ou animal contenant ou susceptible de contenir un microorganisme pathogène infectieux, caractérisé en ce qu'on mélange ledit échantillon biologique avec un alcool pour inactiver le ou lesdits microorganismes pathogènes qu'il contient notamment les virus.The present invention relates to a method of treating a biological sample of a clinical sample from a human or animal patient containing or likely to contain an infectious pathogenic microorganism, characterized in that said biological sample is mixed with an alcohol in order to inactivate said microorganism (s). pathogens that it contains, in particular viruses.

FR1500500A 2015-03-13 2015-03-13 METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE Expired - Fee Related FR3033576B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1500500A FR3033576B1 (en) 2015-03-13 2015-03-13 METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1500500 2015-03-13
FR1500500A FR3033576B1 (en) 2015-03-13 2015-03-13 METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE

Publications (2)

Publication Number Publication Date
FR3033576A1 FR3033576A1 (en) 2016-09-16
FR3033576B1 true FR3033576B1 (en) 2018-11-16

Family

ID=53514236

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1500500A Expired - Fee Related FR3033576B1 (en) 2015-03-13 2015-03-13 METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE

Country Status (1)

Country Link
FR (1) FR3033576B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU490824A1 (en) * 1974-08-27 1975-11-05 Институт полиомиелита и вирусных энцефалитов АМН СССР Method of inactivating infectiousness of viruses
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
WO1988009655A1 (en) * 1987-06-05 1988-12-15 Al Sioufi Habib Method and device for disinfecting biological fluids and container for same
US5149718A (en) * 1989-01-19 1992-09-22 New York University Biological fluid purification system
EA005917B1 (en) * 2001-02-28 2005-06-30 Томас У. Коноволчук Virucidal compositions

Also Published As

Publication number Publication date
FR3033576A1 (en) 2016-09-16

Similar Documents

Publication Publication Date Title
MA47399B1 (en) Derivatives of 7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] oxazin-2-one as inhibitors of the mutated form of idh1 and idh2 proteins
EA202091602A1 (en) SYSTEMS AND METHODS FOR PROCESSING BIOLOGICAL FLUIDS
MA50667A (en) MULTISPECIFIC ANTIGEN-BINDING MOLECULE HAVING SUBSTITUTION ACTIVITY FOR THE FUNCTION OF BLOOD COAGULATION FACTOR VIII COFACTOR (FVIII), AND PHARMACEUTICAL FORMULATION CONTAINING THE SAME MOLECULE AS ACTIVE PRINCIPLE
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
ATE506951T1 (en) TERTIARY CARBINAMINES ACTIVE AS INHIBITORS OF BETA-SECRETASE WITH SUBSTITUTED HETEROCYCLES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MA44549A1 (en) Immunoregulatory agents
EA202090858A1 (en) FIGHT AGAINST MOSAIC VIRUSES AND BACTERIAL INFECTIONS IN PLANTS
EA201000556A1 (en) SPYROPYRROLIDINES AND THEIR APPLICATION TO FIGHT AGAINST INFECTING THROUGH HCV (HEPATITIS C VIRUS) AND HIV (HUMAN IMMUNODEFICIENUS VIRUS)
EA201791535A1 (en) NEW CONNECTION 4'-TIONOUCLEOSIDE, AND ALSO THE WAY OF ITS OBTAINING, ITS PHARMACEUTICAL COMPOSITION AND APPLICATION
MA44948A1 (en) Bace 1 inhibitors
DE60118743D1 (en) METHOD FOR THE TREATMENT AND PREVENTION OF INFECTIOUS DISEASES
CY1122689T1 (en) PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
EA202091118A1 (en) ANTIBACTERIAL COMPOUNDS
WO2005051318A3 (en) Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
FR3033576B1 (en) METHOD OF INACTIVATING AN INFECTIOUS AGENT IN A BIOLOGICAL SAMPLE
CN1639575A (en) In vitro model for priocidal activity
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
FR3068688B1 (en) BACTERIAL COMPOSITION AND USE FOR THE TREATMENT OF WASTEWATER AND THE TREATMENT OF WASTE
Marzouk et al. In vitro inactivation of two Egyptian A/H5N1 viruses by four commercial chemical disinfectants
FR3058417B1 (en) PROCESS FOR TREATING KERATINIC MATERIALS FROM DERIVATIVES OF ACIDIC ESTERS OR AMIDES C-GLYCOSIDES AND THE COSMETIC COMPOSITION CONTAINING THEM
FR3095339B1 (en) Bacteria of the Christensenellaceae family in the prevention and/or treatment of hypertriglyceridemia
CN205709976U (en) A kind of efficient and safe ultraviolet ray disinfector
MA39533B1 (en) Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases
Lin et al. Antimicrobial activity of a novel peracetic acid disinfectants of Bioxy H on resistant pathogens
FR3097124A1 (en) perfume and lithotherapy stone

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160916

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20211105